Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in T2DM and Metabolic Syndrome
NCT00573950Phase 4Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cilostazol in type 2 diabetes mellitus (T2DM) and metabolic syndrome, sponsored by Korea University Anam Hospital. Status: unknown.
02
Drugs
cilostazol
03
Conditions
type 2 diabetes mellitus (T2DM)metabolic syndrome
Beyond the preview
Go deeper on NCT00573950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573950.